articleTop 1% cited
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program
Leukemia · 2003 · Vol. 17(12) · pp. 2474–2486
Emmanuel Beillard✉(Institut Paoli-Calmettes)Niels Pallisgaard(Aarhus University Hospital)Vincent H. J. van der Velden(Erasmus MC)W BiRob DeeC. Ellen van der SchootÉric Delabesse(Hôpital Necker-Enfants Malades)Elizabeth Macintyre(Hôpital Necker-Enfants Malades)Enrico Gottardi(University of Turin)Giuseppe Saglio(Ospedale San Luigi Gonzaga)Franz Watzinger(St Anna Children's Hospital)Thomas Lion(St Anna Children's Hospital)Jacques J. M. van Dongen(Erasmus MC)Peter Hokland(Aarhus University Hospital)J Gäbert(Institut Paoli-Calmettes)
Molecular Biology Techniques and ApplicationsRNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesMinimal residual diseaseFusion geneReal-time polymerase chain reactionBiologyGenePolymerase chain reactionReverse transcriptaseABLCancerTaqMan
MeSH terms
ArchivesEuropeHumansLeukemiaNeoplasm ProteinsProspective StudiesReference ValuesSensitivity and SpecificityTranscription, GeneticReproducibility of ResultsOncogene Proteins, FusionGene Expression Regulation, LeukemicDNA, ComplementaryReverse Transcriptase Polymerase Chain Reaction
Citations
882
FWCI
13.33
field-weighted impact
References
42
Percentile
99%
vs. same field & year
Citations per year
Cited by
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
Leukemia · 2003 · 1,520 citations
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Journal of Clinical Investigation · 2008 · 1,810 citations
References
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.